See the DrugPatentWatch profile for Zidovudine
What is Zidovudine and What is it Used For?
Zidovudine, also known as AZT, is an antiretroviral medication. It is primarily used to treat HIV infection. It works by preventing the human immunodeficiency virus (HIV) from multiplying in the body [1]. Zidovudine is also used to prevent the transmission of HIV from an infected mother to her child during pregnancy, labor, and delivery [1].
How Has Zidovudine Pricing Evolved Over Time?
The pricing trends for Zidovudine have seen significant shifts since its introduction. Initially approved in 1987, Zidovudine was one of the first antiretroviral drugs available for HIV treatment. Its early price was a subject of considerable debate and concern [2]. Over the years, as more effective HIV medications became available and generic versions of Zidovudine entered the market, its price has generally decreased. However, specific pricing can vary based on factors like manufacturer, dosage, and geographic location. DrugPatentWatch.com tracks patent expirations and market exclusivity, which can influence pricing dynamics [3].
When Does Zidovudine's Patent Exclusivity Expire?
Zidovudine's original patents have long expired, allowing for the production and sale of generic versions of the drug. This patent expiry has been a key factor in making the medication more accessible and affordable [2][3].
Can New Versions or Competitors Enter the Market?
With the expiration of Zidovudine's primary patents, generic manufacturers have been able to produce and market their own versions of the drug. This has led to increased competition and generally lower prices compared to the brand-name drug when it was under patent protection.
What Factors Influence Zidovudine's Price Today?
Currently, the price of Zidovudine is largely influenced by the generic market. Competition among multiple generic manufacturers tends to drive prices down. Other factors include manufacturing costs, distribution channels, and the availability of newer, potentially more advanced HIV treatments that may impact demand for Zidovudine.
What Are the Patient and Prescriber Considerations for Zidovudine?
For patients, the primary consideration is the cost and availability of Zidovudine, especially for those in resource-limited settings. Prescribers consider Zidovudine as part of a combination therapy for HIV treatment, weighing its efficacy, potential side effects, and drug interactions against newer agents. While it remains a part of some treatment regimens, its role may differ compared to its initial widespread use due to the advent of more potent and tolerable antiretrovirals.
Sources:
[1] https://www.nhs.uk/medicine-shakespeare/drugs/zidovudine/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744533/
[3] https://drugpatentwatch.com/